Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290484 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT01290484: Completed Phase 1 study, sponsored by Stanford University.
NCT01290484 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01290484, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
There is an unsatisfied medical need for a first-line treatment of lymphatic malformations with a good benefit/risk profile. Based on a patient experience in the institution, the investigators plan to verify whether or not the medication sildenafil has a beneficial effect on lymphatic malformations. The investigators plan to do this by treating patients with lymphatic malformations with the medication sildenafil for a 20 week period. This is an investigator initiated study funded by an Innovations in Patient Care grant and a SPARK grant.
Interventions
- DRUG Sildenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01290484
The ClinicalTrials.gov registry entry for NCT01290484 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sildenafil is the first listed.
NCT01290484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01290484 about?
NCT01290484 is a clinical study titled "A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations". There is an unsatisfied medical need for a first-line treatment of lymphatic malformations with a good benefit/risk profile. Based on a patient experience in the institution, the investigators plan to verify whether or not the medication sildenafil has a beneficial effect on lymphatic malformations....
What is the current status of trial NCT01290484?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2010-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01290484?
The interventions under investigation include: Sildenafil (DRUG).
Who is sponsoring clinical trial NCT01290484?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.